BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36465808)

  • 1. Emergence of Ceftazidime-Avibactam Resistance and Decreased Virulence in Carbapenem-Resistant ST11
    Xu M; Qian C; Jia H; Feng L; Shi S; Zhang Y; Wang L; Cao J; Zhou T; Zhou C
    Infect Drug Resist; 2022; 15():6881-6891. PubMed ID: 36465808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic of KPC-12, a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in the Carbapenem-Resistant
    Han W; Zhou P; Chen C; Wu C; Shen L; Wan C; Xiao Y; Zhang J; Wang B; Shi J; Yuan X; Gao H; Wang H; Zhou Y; Yu F
    Infect Drug Resist; 2024; 17():2541-2554. PubMed ID: 38933778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms Driving the
    Li X; Ke H; Wu W; Tu Y; Zhou H; Yu Y
    mSphere; 2021 Dec; 6(6):e0085921. PubMed ID: 34935448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime-Avibactam Resistance in
    Li D; Li K; Dong H; Ren D; Gong D; Jiang F; Shi C; Li J; Zhang Q; Yan W; Li Y
    Infect Drug Resist; 2021; 14():1725-1731. PubMed ID: 34007191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in a Widespread ST11 Carbapenem-Resistant
    Li X; Quan J; Ke H; Wu W; Feng Y; Yu Y; Jiang Y
    Front Microbiol; 2021; 12():724272. PubMed ID: 34484166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Within-Host Resistance and Virulence Evolution of a Hypervirulent Carbapenem-Resistant
    Zhou C; Zhang H; Xu M; Liu Y; Yuan B; Lin Y; Shen F
    Infect Drug Resist; 2023; 16():7255-7270. PubMed ID: 38023413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic evolution of ceftazidime-avibactam resistance due to interchanges between
    Chen Y; Yang R; Guo P; Liu P; Deng J; Wu Z; Wu Q; Huang J; Liao K
    Front Cell Infect Microbiol; 2023; 13():1244511. PubMed ID: 37671146
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wang C; Zhao J; Liu Z; Sun A; Sun L; Li B; Lu B; Liu Y; Cao B
    Front Microbiol; 2021; 12():727946. PubMed ID: 34630354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Hypervirulent ST11-K64
    Wei T; Zou C; Qin J; Tao J; Yan L; Wang J; Du H; Shen F; Zhao Y; Wang H
    Front Public Health; 2022; 10():765624. PubMed ID: 35309213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
    Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
    Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant
    Han X; Shi Q; Mao Y; Quan J; Zhang P; Lan P; Jiang Y; Zhao D; Wu X; Hua X; Yu Y
    Front Cell Infect Microbiol; 2021; 11():757470. PubMed ID: 34760723
    [No Abstract]   [Full Text] [Related]  

  • 12. Whole genome sequencing of OXA-232-producing
    Tian C; Xing M; Zhao Y; Fan X; Bai Y; Fu L; Wang S
    Front Cell Infect Microbiol; 2022; 12():984479. PubMed ID: 36250056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission Dynamics of Carbapenem-Resistant
    Kong Y; Sun Q; Chen H; Draz MS; Xie X; Zhang J; Ruan Z
    Front Microbiol; 2021; 12():736896. PubMed ID: 34690977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
    Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B
    Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Description of Ceftazidime/Avibactam Resistance in a ST13 KPC-70-Producing
    Mendes G; Ramalho JF; Bruschy-Fonseca A; Lito L; Duarte A; Melo-Cristino J; Caneiras C
    Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Coharboring a
    Ahmed MAEE; Yang Y; Yang Y; Yan B; Chen G; Hassan RM; Zhong LL; Chen Y; Roberts AP; Wu Y; He R; Liang X; Qin M; Dai M; Zhang L; Li H; Yang F; Xu L; Tian GB
    mSphere; 2021 May; 6(3):. PubMed ID: 34011682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotic resistance and virulence characteristics analysis of a carbapenem-resistant hypervirulent
    Chen JW; Lu JY; Zhang R; Cai JC
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(31):2478-2484. PubMed ID: 34399563
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiological and Molecular Characteristics of
    Rong F; Liu Z; Yang P; Wu F; Sun Y; Sun X; Zhou J
    Infect Drug Resist; 2023; 16():2247-2258. PubMed ID: 37090038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Molecular Epidemiologic Characteristics of Ceftazidime/Avibactam-Resistant Carbapenem-Resistant
    Zhou J; Yang J; Hu F; Gao K; Sun J; Yang J
    Infect Drug Resist; 2020; 13():2571-2578. PubMed ID: 32801794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of Hypervirulent Ceftazidime/Avibactam-Resistant
    Li D; Liao W; Huang HH; Du FL; Wei DD; Mei YF; Long D; Wan LG; Liu Y; Zhang W
    Infect Drug Resist; 2020; 13():2673-2680. PubMed ID: 32821131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.